The Prolistem treatment has emerged as a breakthrough for men grappling with non-obstructive azoospermia, a condition that can be incredibly challenging to address. Its efficacy and safety have been rigorously assessed and endorsed by the Turkish Urology Association, elevating it to the esteemed status of the gold standard in pre-microTESE care. This approval signifies not only its effectiveness in addressing the root causes of azoospermia but also its potential to enhance the success rates of subsequent microTESE procedures. With Prolistem paving the way as a trusted intervention, hope shines brighter for individuals navigating the complexities of male infertility.
The article: https://www.uroturk.org.tr/urolojiData/Books/991/prolistem-in-non-obstruktif-azospermide-klinik-kullanimi.pdf
Introduction Male infertility, especially caused by azoospermia, affects millions of men worldwide. For those suffering from non-obstructive azoospermia, treatment options have been limited. However, thanks
Azoospermia is one of the most challenging causes of male infertility, often leaving men with few options and couples struggling to conceive. But today, an
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
PROLISTEM® is a Patented Formula
Copyright © 2025 Prolistem®
